drugset / Trial / NCT01834352

Walnut Oral Immunotherapy for Tree Nut Allergy

NCT01834352 ↗

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine if walnut oral immunotherapy can be used in subjects allergic to tree nuts to decrease their tree nut allergy and induce changes in their immune system.

Timeline

Start
2013-11
Primary completion
2013-12
Completion
2013-12

Outcome

Outcome not reported

Stopped: “Concern for cross contamination in weighing tree nuts in facility with peanuts”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Walnut Protein Flour Unknown — Oral

Indications

No indication recorded.